Literature DB >> 30324540

Factors associated with unfavorable outcome in a multicenter audit of 100 infective endocarditis.

David Chirio1, Marion Le Marechal2, Pamela Moceri3, Arnaud de la Chapelle4, Sylvie Chaillou-Optiz5, Anaïs Mothes6, Cédric Foucault7, Laurence Maulin8, Chirine Parsaï9, Pierre-Marie Roger2, Elisa Demonchy2.   

Abstract

We aimed to identify factors associated with unfavorable outcome in patients treated for infective endocarditis (IE), with a focus on departure from European guidelines. We conducted a retrospective audit of all adult patients treated for endocarditis during a 1-year period across a regional network of nine care centers in the south-east of France. Medical records were reviewed regarding patient and infection characteristics, antibiotic therapy, outcome, and compliance to the European Society of Cardiology guidelines. Antibiotic treatment appropriateness was evaluated regarding molecule, dosage, and duration, according to guidelines. Primary endpoint was the assessment of factors associated with unfavorable outcome, defined as in-hospital mortality or IE relapse at 1-year follow-up. Secondary endpoints were intensive care admission, iatrogenic events, and nosocomial infections that occurred during hospital stay. One hundred patients were included. Median age was 71 years old. Twenty-two patients died and IE relapse occurred in two patients, representing 24 patients with unfavorable outcome. Overall, antibiotic treatment was deemed appropriate in 28 cases. Thirty-three patients required intensive care, 34 iatrogenic events were found, including 19 acute kidney injuries, and 13 nosocomial infections occurred during care. Using a logistic regression, factors associated with unfavorable outcome were admission in the intensive care unit (adjusted odd ratio 7.26 [1.8-29.28]; p = 0.005), new-onset nosocomial infection (adjusted odd ratio 8.83 [1.42-54.6]; p = 0.019), and age > 71 years old (adjusted odd ratio 11.2 [2.76-46.17]; p < 0.001). Departure from guidelines was frequent but not related to unfavorable outcome in our study. Only intensive care, age, and nosocomial infections were associated with mortality and relapse. Iatrogenic events were numerous, with no impact on outcome.

Entities:  

Keywords:  Antibiotic therapy; Audit; Guidelines; Iatrogenic event; Infective endocarditis

Mesh:

Substances:

Year:  2018        PMID: 30324540     DOI: 10.1007/s10096-018-3401-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011.

Authors:  Sadip Pant; Nileshkumar J Patel; Abhishek Deshmukh; Harsh Golwala; Nilay Patel; Apurva Badheka; Glenn A Hirsch; Jawahar L Mehta
Journal:  J Am Coll Cardiol       Date:  2015-05-19       Impact factor: 24.094

2.  Audit of antibiotic therapy used in 66 cases of endocarditis.

Authors:  E Demonchy; P Dellamonica; P M Roger; E Bernard; E Cua; C Pulcini
Journal:  Med Mal Infect       Date:  2011-09-15       Impact factor: 2.152

3.  Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis.

Authors:  Fabio Chirillo; Piergiorgio Scotton; Francesco Rocco; Roberto Rigoli; Francesca Borsatto; Alessandra Pedrocco; Alessandro De Leo; Giuseppe Minniti; Elvio Polesel; Zoran Olivari
Journal:  Am J Cardiol       Date:  2013-07-05       Impact factor: 2.778

Review 4.  Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature.

Authors:  Aref A Bin Abdulhak; Larry M Baddour; Patricia J Erwin; Bruno Hoen; Vivian H Chu; George A Mensah; Imad M Tleyjeh
Journal:  Glob Heart       Date:  2014-03

5.  Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices.

Authors:  Bernard Iung; Thanh Doco-Lecompte; Sidney Chocron; Christophe Strady; François Delahaye; Vincent Le Moing; Claire Poyart; François Alla; Emmanuelle Cambau; Pierre Tattevin; Catherine Chirouze; Jean-François Obadia; Xavier Duval; Bruno Hoen
Journal:  Eur Heart J       Date:  2015-12-18       Impact factor: 29.983

6.  Low-dose Gentamicin for Uncomplicated Enterococcus faecalis Bacteremia May be Nephrotoxic in Children.

Authors:  Sarai Little Ibrahim; Long Zhang; Tammy M Brady; Alice J Hsu; Sara E Cosgrove; Pranita D Tamma
Journal:  Clin Infect Dis       Date:  2015-06-16       Impact factor: 9.079

7.  How do physicians cope with controversial topics in existing guidelines for the management of infective endocarditis? Results of an international survey.

Authors:  G Béraud; C Pulcini; J R Paño-Pardo; B Hoen; B Beovic; D Nathwani
Journal:  Clin Microbiol Infect       Date:  2015-10-20       Impact factor: 8.067

8.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Authors:  Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

9.  Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Authors:  Gilbert Habib; Bruno Hoen; Pilar Tornos; Franck Thuny; Bernard Prendergast; Isidre Vilacosta; Philippe Moreillon; Manuel de Jesus Antunes; Ulf Thilen; John Lekakis; Maria Lengyel; Ludwig Müller; Christoph K Naber; Petros Nihoyannopoulos; Anton Moritz; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

10.  [Infectious endocarditis: degree of discordance between clinical guidelines recommendations and clinical practice].

Authors:  Mercedes González De Molina; Juan C Fernández-Guerrero; José Azpitarte
Journal:  Rev Esp Cardiol       Date:  2002-08       Impact factor: 4.753

View more
  1 in total

1.  Infective endocarditis at a tertiary care hospital in South Korea.

Authors:  Jung Ho Kim; Hi Jae Lee; Nam Su Ku; Seung Hyun Lee; Sak Lee; Jun Yong Choi; Joon-Sup Yeom
Journal:  Heart       Date:  2020-10-08       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.